In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog
- 360 Downloads
Limited tumor penetrability of anti-cancer drugs is recognized as one of the major factors that lead to poor anti-tumor activity. SRJ09 (3,19-(2-bromobenzylidene) andrographolide) has been identified as a lead anti-cancer agent for colon cancer. Recently, this compound was shown by us to be a mutant K-Ras binder. In this present study, the penetrability of SRJ09 through the DLD-1 colon cancer multicell layer (MCL) was evaluated. The amount of SRJ09 that penetrated through the MCL was quantitated by utilizing high performance liquid chromatography (HPLC). Histopathological staining was used to visualize the morphology of MCL. A chemosensitivity assay was performed to assess the anti-cancer activity of SRJ09 in DLD-1 cells. SRJ09 was able to penetrate through DLD-1 MCL and is inversely proportional with the MCL thickness. The flow rates for SRJ09 through MCL were 0.90 ± 0.20 μM/min/cm2 and 0.56 ± 0.06 μM/min/cm2 for days 1 and 5, respectively, which are better than doxorubicin. Histopathological examination revealed that the integrity of the DLD-1 MCL was retained and no visible damage was inflicted on the cell membrane, confirming the penetration of SRJ09 was by diffusion. Short term exposure (1 h) in DLD-1 cells demonstrated SRJ09 had IC50 of 41 μM which was approximately 4-folds lower than andrographolide, the parent compound of SRJ09. In conclusion, SRJ09 successfully penetrated through DLD-1 MCL by diffusion and emerged as a potential candidate to be developed as a clinically viable anti-colon cancer drug.
KeywordsAndrographolide analogue Colon cancer Tumor penetration DLD-1 Multi cell layer
The project was funded by the Research University Grant Scheme (RUGS) (Grant: 04-01-09-0713RU; 04-02-12-2017RU) through the Ministry of Higher Education. The European Association for Cancer Research (EACR) is thanked for providing a travel fellowship to Charng Choon Wong.
Conflict of interest
The authors state no conflict of interest.
- 9.Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, Nogueira V, Hay N, Sarkar FH (2010) Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappa B-signalling pathways. J Cell Biochem 109:426–436Google Scholar
- 15.Kurenova EV, Hunt DL, He D, Fu AD, Massoll NA, Golubovskaya VM, Garces CA, Cance WG (2009) Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo. Cell Cycle 8:2266–2280PubMedCentralCrossRefPubMedGoogle Scholar
- 21.Toppmeyer D, Seidman AD, Pollak M, Russell C, Tkaczuk K, Verma S, Overmoyer B, Garg V, Ette E, Harding MW et al (2002) Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel. Clin Cancer Res 8:670–678PubMedGoogle Scholar
- 23.Okada T, Tanaka K, Nakatani F, Sakimura R, Matsunobu T, Li X, Hanada M, Nakamura T, Oda Y, Tsuneyoshi M et al (2006) Involvement of P-glycoprotein and MRP1 in resistance to cyclic tetrapeptide subfamily of histone deacetylase inhibitors in the drug-resistant osteosarcoma and Ewing’s sarcoma cells. Int J Cancer 118:90–97CrossRefPubMedGoogle Scholar
- 33.Hicks KO, Pruijn FB, Secomb TW, Hay MP, Hsu R, Brown JM, Denny WA, Dewhirst MW, Wilson WR (2006) Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs. J Natl Cancer Inst 98(16):1118–1128 Google Scholar
- 35.Hansch C, Leo A, Hoekman D (1995) Exploring QSAR: Hydrophobic, Electronic, and Steric Constants. American Chemistry Society, Washington, DC. ISBN 978-0-8412-3060-6Google Scholar
- 36.Lim SH (2007). Mechanisms of Antitumour Activity of 3,19-(2 Bromobenzylidene) Andrographolide (SRJ09). Master thesis, Universiti Putra Malaysia. (http://psasir.upm.edu.my/6965/).
- 40.Chhikara BS, Mandal D, Parang K (2012) Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate. J Med Chem 55(4):1500–1510Google Scholar
- 43.Sagineedu SR. Semisynthesis of selected andrographolide derivatives and in vitro evaluation for cytotoxic and antiangiogenic properties. PhD Thesis, Universiti Putra Malaysia, Malaysia, 2012.Google Scholar
- 46.Thant AA, Wu Y, Lee J, Mishra DK, Garcia H, Koeffler HP, Vadgama JV (2008) Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells. Anti-cancer Res 28(6A):3579–92Google Scholar